We previously demonstrated that promyelocytic leukemia/retinoic acid receptor alpha (PML/RARa) hybrid protein inhibits Nrf2 function, impedes its transfer to the nucleus, and enhances its degradation in the cytoplasm, but mRNA levels are similar to those found in other AML subtypes. Here, RARA is linked to acute myeloid leukemia.